Access Cannabis Patients Retail 
NORML
APRIL 28, 2023
"For almost ten years, patients and their providers have lacked the ability to locally access these medically necessary state-approved products from state-licensed retailers. The post Georgia: Regulators Finally License Retailers to Begin Selling Low-THC Cannabis Products to Authorized Patients appeared first on NORML.
NORML
APRIL 3, 2020
In recent days, numerous states have taken steps to ensure that state-licensed cannabis facilities are explicitly permitted to maintain operations during the COVID-19 pandemic. In several jurisdictions, lawmakers have designated these operations to be ‘essential’ to the health and well-being of the patient community.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MARCH 25, 2020
In recent days, numerous states have taken steps to ensure that state-licensed cannabis facilities are explicitly permitted to maintain operations during the COVID-19 pandemic. In several jurisdictions, lawmakers have designated these operations to be ‘essential’ to the health and well-being of the patient community.
NORML
APRIL 14, 2020
In recent days, numerous states have taken steps to ensure that state-licensed cannabis facilities are explicitly permitted to maintain operations during the COVID-19 pandemic. In several jurisdictions, lawmakers have designated these operations to be ‘essential’ to the health and well-being of the patient community.
Veriheal
JULY 26, 2023
Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets. Eligible patients were granted access to low-THC marijuana oil.
NORML
JULY 2, 2019
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.
Cannabis Law Report
FEBRUARY 26, 2022
The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It
Expert insights. Personalized for you.
206 
Let's personalize your content